The following is a summary of the “Anterior Cervical Corpectomy and Fusion for Degenerative Cervical Spondylotic Myelopathy” published in the December 2022 issue of Clinical Spine Surgery by Louie et al.

Patients who present with cervical spondylotic myelopathy may be candidates for anterior cervical corpectomy and fusion (ACCF), which provides a significant degree of decompression as well as a vast surface area on which fusion can take place. Patients who arrive with this condition may also be candidates for posterior cervical corpectomy and fusion (PCCF). It is regrettable that this treatment requires a more sophisticated spinal surgery to carry out (in comparison with a standard anterior cervical discectomy and fusion), and it also has a higher incidence of complications in general. 

According to the findings of the research that has been published, anterior cervical discectomy and fusion (ACCF) produce functional outcomes that are clinically comparable to those produced by multilevel anterior cervical discectomy and fusion. This is especially the case when the operation is only performed on one level of vertebral body level, in circumstances in which both posterior and anterior treatments would be viable surgical alternatives, ACCF may provide a larger long-term therapeutic benefit than posterior fusion or laminoplasty would. 

In this article, researchers address the outcomes of treatment with ACCF for degenerative cervical spondylotic myelopathy and the reasons for receiving such treatment. Following that, investigators have a conversation about a case presentation and the surgical strategy that was taken in conjunction with that, and then they move on to a discussion about how to avoid complications while undergoing this treatment.